<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0912211447
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2002
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZOVIRAX
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ACYCLOVIR
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        74.40
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLAXO SAUDI ARABIA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1182]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J05AB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Zovirax Tablets 200 mg, 400 mg and 800 mg (called &lsquo;Zovirax&rsquo; in this leaflet) contains a medicine called aciclovir. This belongs to a group of medicines called antivirals. It works by killing or stopping the growth of viruses.</p><p>Zovirax can be used to:</p><p>&middot;&nbsp;&nbsp;&nbsp; treat chickenpox and shingles</p><p>&middot;&nbsp;&nbsp;&nbsp; treat cold sores, genital herpes and other herpes simplex infections</p><p>&middot;&nbsp;&nbsp;&nbsp; stop these problems returning after you have had them</p><p>&middot;&nbsp;&nbsp;&nbsp; stop these problems in people whose immune systems work less well, which means their bodies are less able to fight infections.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Zovirax:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; if you are allergic to aciclovir or valaciclovir or any of the other ingredients of this medicine (listed in Section 6).</p><p>Do not take Zovirax if the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Zovirax.</p><p><strong>Warnings and precautions</strong></p><p>Talk to your<strong> </strong>doctor or pharmacist before taking Zovirax if:</p><p>&middot;&nbsp;&nbsp;&nbsp; you have kidney problems</p><p>&middot;&nbsp;&nbsp;&nbsp; you are over 65 years of age.</p><p>If you are not sure if the above apply to you, talk to your doctor or pharmacist before taking Zovirax.</p><p>It is important that you drink plenty of water while taking Zovirax</p><p><strong>Other medicines and Zovirax</strong></p><p>Tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription, including herbal medicines.</p><p>In particular tell your doctor or pharmacist if you are taking any of the following medicines:</p><p>&middot;&nbsp;&nbsp;&nbsp; probenecid, used to treat gout</p><p>&middot;&nbsp;&nbsp;&nbsp; cimetidine, used to treat stomach ulcers</p><p>&middot;&nbsp;&nbsp;&nbsp; mycophenolate mofetil, used to stop your body rejecting transplanted organs.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using any medicine.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Some side effects such as feeling drowsy or sleepy may impair your ability to concentrate and react. Make sure you are not affected before you drive or operate machinery.</p><p>&nbsp;</p><p><strong>Important information about the contents of Zovirax Tablets</strong></p><p>This medicine contains less than 1mmol sodium (23 mg) per dosage unit, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>Taking this medicine</strong>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take this medicine by mouth</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Dissolve the tablet in a glass of water and stir before drinking</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you prefer, the tablet can also be swallowed whole with a little water</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Start to take Zovirax as soon as possible</p><p>&nbsp;</p><p>The dose that you should take will depend on what you have been given Zovirax for. Your doctor will discuss this with you.</p><p><strong>Treatment of chickenpox and shingles</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual dose is 800 mg tablets taken five times a day</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should space each dose by 4 hours</p><p>Suggested times are: <strong>7am, 11am, 3pm, 7pm and 11pm</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should take Zovirax for seven days.</p><p><strong>Treatment of cold sores and genital herpes</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual dose is one 200 mg tablet taken five times a day</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should space each dose by 4 hours</p><p>Suggested times are: <strong>7am, 11am, 3pm, 7pm and 11pm</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should take Zovirax for five days, or longer if your doctor tells you to.</p><p><strong>Stopping these problems returning after you have had them</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual dose is one 200 mg tablet taken four times a day</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should try to space each dose by 6 hours</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should take Zovirax until your doctor tells you to stop</p><p><strong>Stopping these problems in people whose</strong> <strong>immune systems work less well and whose bodies are less able to fight infections</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual dose is one 200 mg tablet taken four times a day</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should try to space each dose by 6 hours&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should take Zovirax until your doctor tells you to stop.<strong> </strong></p><p><strong>Your doctor may adjust the dose of Zovirax if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; it is for a child</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are over 65 years of age</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have kidney problems. If you have kidney problems, it is important to drink plenty of water while you are being treated with Zovirax.</p><p>Talk to your doctor before taking Zovirax if any of the above apply</p><p><strong>If you take more Zovirax than you should</strong></p><p>Zovirax is not usually harmful, unless you take too much over several days. Talk to your doctor or pharmacist if you take too much Zovirax. Take the medicine pack with you.</p><p><strong>If you forget to take Zovirax</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; If you forget to take Zovirax, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Do not take a double dose to make up for a forgotten dose</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:</p><p>&nbsp;</p><p><strong>Allergic reactions </strong>(may affect up to 1 in 1,000 people)</p><p>If you have an allergic reaction, <strong>stop taking Zovirax and see a doctor straight away</strong>. The signs may include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash, itching or hives on your skin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of your face, lips, tongue or other parts of your body</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath, wheezing or trouble breathing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; collapse</p><p>&nbsp;</p><p>Other side effects include:</p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling dizzy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling or being sick</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stomach pains</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin reaction after exposure to light (photosensitivity)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling tired</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unexplained fever (high temperature) and feeling faint, especially when standing up.</p><p>&nbsp;</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy, hive-like rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hair loss.</p><p>&nbsp;</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effects on some blood and urine tests</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increases in the enzymes that work in the liver.</p><p><strong>&nbsp;</strong></p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced numbers of red blood cells (anaemia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced numbers of white blood cells (leukopenia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced numbers of blood platelets (cells that help blood to clot) (thrombocytopenia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling weak</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling agitated or confused</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shaking or tremors</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hallucinations (seeing or hearing things that aren&rsquo;t there)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fits</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling unusually sleepy or drowsy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unsteadiness when walking and lack of coordination</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty speaking</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inability to think or judge clearly</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unconsciousness (coma)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; paralysis of part or all of your body</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disturbances of behaviour, speech and eye movements</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stiff neck and sensitivity to light</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the liver (hepatitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yellowing of your skin and whites of your eyes (jaundice)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; kidney problems where you pass little or no urine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain in your lower back, the kidney area of your back or just above your hip (renal pain)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Keep out of reach and sight of children.</strong></p><p>&middot;&nbsp; Do not use ZOVIRAX Tablets after the expiry date which is stated on the pack after &lsquo;Exp&rsquo;.</p><p>&middot;&nbsp; Store ZOVIRAX tablets in the original pack in a dry place at below 25&deg;C. The tablets should be dispensed in moisture proof containers.</p><p>&middot;&nbsp; Do not use ZOVIRAX if the tablets are chipped or there are other visible signs of deterioration.</p><p>&middot;&nbsp; If your doctor tells you to stop taking ZOVIRAX Tablets, it is important to return any tablets which are left over to your pharmacist.</p><p>&middot;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What ZOVIRAX Tablets contains</strong></p><p>&middot;&nbsp; Active ingredients:</p><p><strong>ZOVIRAX</strong><em> </em>Tablets 200 mg contains 200 mg Acyclovir.</p><p><strong>ZOVIRAX</strong><em> </em>Tablets 400 mg contains 400 mg Acyclovir.</p><p><strong>ZOVIRAX</strong><em> </em>Tablets 800 mg contains 800 mg Acyclovir.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other ingredients include:</p><p>Microcrystalline cellulose, sodium starch glycollate, povidone K30, magnesium stearate, lactose monohydrate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Zovirax looks like and contents of the pack
PVC/PVdC/ Aluminium foil blister packs.
Pack size:
Zovirax 200 mg : 25 Tablets
Zovirax 400 mg : 70 Tablets
Zovirax 800 mg : 35 Tablets

Version number: UKSmPC 
Date of issue: 10/06/2021
ZOVIRAX is a trademark owned by or licensed to GSK group of companies

© 2024 GSK group of companies.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufactured by:</strong></p><p>Glaxo Wellcome S.A.*, Aranda, Spain</p><p>Avenida de Extremadura, 3. 09400 Aranda de Duero, Burgos (Spain)</p><p><strong>Packaged by</strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, Kingdom of Saudi Arabia</p><p><strong>Marketing Authorisation Holder </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA</p><p>*member of the GlaxoSmithKline group of companies</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>-GSK - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com</li><li>website: https://gskpro.com/en-sa/<u> </u></li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul><p><strong>&nbsp;</strong></p><p><!--[if gte vml 1]><v:roundrect id="Rectangle_x003a__x0020_Rounded_x0020_Corners_x0020_2"
 o:spid="_x0000_s1027" style='position:absolute;margin-left:7pt;margin-top:3.65pt;
 width:481.9pt;height:235.15pt;z-index:251658241;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' arcsize="10923f"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokeweight="2.5pt">
 <v:shadow color="#868686"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal style='text-autospace:none'><b><span style='font-size:
    14.0pt'>To report any side effect(s):<o:p></o:p></span></b></p>
    <p class=MsoNormal style='text-autospace:none'><b><i><o:p>&nbsp;</o:p></i></b></p>
    <p class=MsoNormal style='text-autospace:none'><b><i>Kingdom of Saudi
    Arabia<o:p></o:p></i></b></p>
    <p class=MsoNormal style='text-autospace:none'><b><span style='font-size:
    10.5pt'>-National Pharmacovigilance centre (NPC)</span></b><b><span
    style='font-size:10.5pt;mso-fareast-language:EN-US'><o:p></o:p></span></b></p>
    <ul style='margin-top:0cm' type=disc>
     <li class=MsoNormal style='line-height:115%;mso-list:l0 level1 lfo2'>Reporting
         hotline: 19999<o:p></o:p></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l0 level1 lfo2'><span
         lang=FR-BE style='mso-ansi-language:FR-BE'>E-mail: </span><a
         href="mailto:npc.drug@sfda.gov.sa"><span lang=FR style='mso-ansi-language:
         FR'>npc.drug@sfda.gov.sa </span></a><span lang=FR-BE style='mso-ansi-language:
         FR-BE'><o:p></o:p></span></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l0 level1 lfo2'>Website:
         <a href="https://ade.sfda.gov.sa/">https://ade.sfda.gov.sa</a><b><span
         style='font-size:10.5pt;line-height:115%'><o:p></o:p></span></b></li>
    </ul>
    <p class=MsoNormal><b><span style='font-size:10.5pt'>-GSK <span
    style='mso-spacerun:yes'> </span>- Head Office, Jeddah</span></b><b><span
    style='font-size:10.5pt;mso-fareast-font-family:Calibri'><o:p></o:p></span></b></p>
    <ul style='margin-top:0cm' type=disc>
     <li class=MsoNormal style='line-height:115%;mso-list:l1 level1 lfo1'>Tel:&nbsp;
         +966-12-6536666<span style='mso-bidi-font-size:11.0pt;line-height:
         115%'><o:p></o:p></span></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l1 level1 lfo1'>Mobile:
         +966-56-904-9882<o:p></o:p></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l1 level1 lfo1'>Email:
         <u>s</u><a href="mailto:audi.safety@gsk.com">audi.safety@gsk.com</a><u><span
         style='mso-spacerun:yes'>  </span></u><span
         style='mso-spacerun:yes'> </span><o:p></o:p></li>
     <li class=MsoNormal style='color:blue;line-height:115%;mso-list:l1 level1 lfo1'><span
         style='color:windowtext'>website: <a href="https://gskpro.com/en-sa/">https://gskpro.com/en-sa/</a><u>
         </u></span><span class=MsoHyperlink><o:p></o:p></span></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l1 level1 lfo1'>P.O.
         Box 55850, Jeddah 21544, Saudi Arabia<o:p></o:p></li>
    </ul>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><v:roundrect id="Rectangle_x003a__x0020_Rounded_x0020_Corners_x0020_3"
 o:spid="_x0000_s1026" style='position:absolute;margin-left:4.6pt;margin-top:255.05pt;
 width:481.9pt;height:171.25pt;z-index:251658242;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' arcsize="10923f"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokeweight="2.5pt">
 <v:shadow color="#868686"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal><b><span style='mso-bidi-font-size:12.0pt;font-family:
    "TimesNewRomanWGL-Bold",serif;mso-bidi-font-family:TimesNewRomanWGL-Bold;
    color:black'>THIS IS A MEDICAMENT</span></b><span style='font-size:10.5pt'><o:p></o:p></span></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    Medicament is a product which affects your health, and its consumption
    contrary to instructions is dangerous for you.<o:p></o:p></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    Follow strictly the doctor’s prescription, the method of use and the
    instructions of the pharmacist who sold the medicament.<o:p></o:p></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    The doctor and the pharmacist are experts in medicine, its benefits and
    risks.<o:p></o:p></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    Do not by yourself interrupt the period of treatment prescribed for you.<o:p></o:p></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    Do not repeat the same prescription without consulting your doctor.<o:p></o:p></p>
    <p class=MsoNormal>- Keep all medicine out of reach of children<o:p></o:p></p>
    <p class=MsoNormal align=right style='text-align:right'>Council of Arab
    Health Ministers<o:p></o:p></p>
    <p class=MsoNormal align=right style='text-align:right'>Union of Arab
    Pharmacists<o:p></o:p></p>
    <p class=MsoNormal><o:p>&nbsp;</o:p></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td colspan="2" style="vertical-align:top"><img width="649" height="320" alt="Rectangle: Rounded Corners: To report any side effect(s):

Kingdom of Saudi Arabia
-National Pharmacovigilance centre (NPC)
•	Reporting hotline: 19999
•	E-mail: npc.drug@sfda.gov.sa 
•	Website: https://ade.sfda.gov.sa
-GSK  - Head Office, Jeddah
•	Tel:  +966-12-6536666
•	Mobile: +966-56-904-9882
•	Email: saudi.safety@gsk.com   
•	website: https://gskpro.com/en-sa/ 
•	P.O. Box 55850, Jeddah 21544, Saudi Arabia
" src="file:///C:/Users/mh360004/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png" /></td></tr><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td colspan="2" style="vertical-align:top"><img width="649" height="235" alt="Rectangle: Rounded Corners: THIS IS A MEDICAMENT
- Medicament is a product which affects your health, and its consumption contrary to instructions is dangerous for you.
- Follow strictly the doctor’s prescription, the method of use and the instructions of the pharmacist who sold the medicament.
- The doctor and the pharmacist are experts in medicine, its benefits and risks.
- Do not by yourself interrupt the period of treatment prescribed for you.
- Do not repeat the same prescription without consulting your doctor.
- Keep all medicine out of reach of children
Council of Arab Health Ministers
Union of Arab Pharmacists

" src="file:///C:/Users/mh360004/AppData/Local/Temp/msohtmlclip1/01/clip_image002.png" /></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Manufactured by:</strong></p><p>Glaxo Wellcome S.A.*, Aranda, Spain</p><p>Avenida de Extremadura, 3. 09400 Aranda de Duero, Burgos (Spain)</p><p><strong>Packaged by</strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, Kingdom of Saudi Arabia</p><p><strong>Marketing Authorisation Holder </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA</p><p>*member of the GlaxoSmithKline group of companies</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;<p><strong>&nbsp;</strong></p></p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>-GSK - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com</li><li>website: https://gskpro.com/en-sa/<u> </u></li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul><p><strong>&nbsp;</strong></p><p><!--[if gte vml 1]><v:roundrect id="Rectangle_x003a__x0020_Rounded_x0020_Corners_x0020_2"
 o:spid="_x0000_s1027" style='position:absolute;margin-left:7pt;margin-top:3.65pt;
 width:481.9pt;height:235.15pt;z-index:251658241;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' arcsize="10923f"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokeweight="2.5pt">
 <v:shadow color="#868686"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal style='text-autospace:none'><b><span style='font-size:
    14.0pt'>To report any side effect(s):<o:p></o:p></span></b></p>
    <p class=MsoNormal style='text-autospace:none'><b><i><o:p>&nbsp;</o:p></i></b></p>
    <p class=MsoNormal style='text-autospace:none'><b><i>Kingdom of Saudi
    Arabia<o:p></o:p></i></b></p>
    <p class=MsoNormal style='text-autospace:none'><b><span style='font-size:
    10.5pt'>-National Pharmacovigilance centre (NPC)</span></b><b><span
    style='font-size:10.5pt;mso-fareast-language:EN-US'><o:p></o:p></span></b></p>
    <ul style='margin-top:0cm' type=disc>
     <li class=MsoNormal style='line-height:115%;mso-list:l0 level1 lfo2'>Reporting
         hotline: 19999<o:p></o:p></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l0 level1 lfo2'><span
         lang=FR-BE style='mso-ansi-language:FR-BE'>E-mail: </span><a
         href="mailto:npc.drug@sfda.gov.sa"><span lang=FR style='mso-ansi-language:
         FR'>npc.drug@sfda.gov.sa </span></a><span lang=FR-BE style='mso-ansi-language:
         FR-BE'><o:p></o:p></span></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l0 level1 lfo2'>Website:
         <a href="https://ade.sfda.gov.sa/">https://ade.sfda.gov.sa</a><b><span
         style='font-size:10.5pt;line-height:115%'><o:p></o:p></span></b></li>
    </ul>
    <p class=MsoNormal><b><span style='font-size:10.5pt'>-GSK <span
    style='mso-spacerun:yes'> </span>- Head Office, Jeddah</span></b><b><span
    style='font-size:10.5pt;mso-fareast-font-family:Calibri'><o:p></o:p></span></b></p>
    <ul style='margin-top:0cm' type=disc>
     <li class=MsoNormal style='line-height:115%;mso-list:l1 level1 lfo1'>Tel:&nbsp;
         +966-12-6536666<span style='mso-bidi-font-size:11.0pt;line-height:
         115%'><o:p></o:p></span></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l1 level1 lfo1'>Mobile:
         +966-56-904-9882<o:p></o:p></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l1 level1 lfo1'>Email:
         <u>s</u><a href="mailto:audi.safety@gsk.com">audi.safety@gsk.com</a><u><span
         style='mso-spacerun:yes'>  </span></u><span
         style='mso-spacerun:yes'> </span><o:p></o:p></li>
     <li class=MsoNormal style='color:blue;line-height:115%;mso-list:l1 level1 lfo1'><span
         style='color:windowtext'>website: <a href="https://gskpro.com/en-sa/">https://gskpro.com/en-sa/</a><u>
         </u></span><span class=MsoHyperlink><o:p></o:p></span></li>
     <li class=MsoNormal style='line-height:115%;mso-list:l1 level1 lfo1'>P.O.
         Box 55850, Jeddah 21544, Saudi Arabia<o:p></o:p></li>
    </ul>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><v:roundrect id="Rectangle_x003a__x0020_Rounded_x0020_Corners_x0020_3"
 o:spid="_x0000_s1026" style='position:absolute;margin-left:4.6pt;margin-top:255.05pt;
 width:481.9pt;height:171.25pt;z-index:251658242;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' arcsize="10923f"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" strokeweight="2.5pt">
 <v:shadow color="#868686"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal><b><span style='mso-bidi-font-size:12.0pt;font-family:
    "TimesNewRomanWGL-Bold",serif;mso-bidi-font-family:TimesNewRomanWGL-Bold;
    color:black'>THIS IS A MEDICAMENT</span></b><span style='font-size:10.5pt'><o:p></o:p></span></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    Medicament is a product which affects your health, and its consumption
    contrary to instructions is dangerous for you.<o:p></o:p></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    Follow strictly the doctor’s prescription, the method of use and the
    instructions of the pharmacist who sold the medicament.<o:p></o:p></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    The doctor and the pharmacist are experts in medicine, its benefits and
    risks.<o:p></o:p></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    Do not by yourself interrupt the period of treatment prescribed for you.<o:p></o:p></p>
    <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'>-
    Do not repeat the same prescription without consulting your doctor.<o:p></o:p></p>
    <p class=MsoNormal>- Keep all medicine out of reach of children<o:p></o:p></p>
    <p class=MsoNormal align=right style='text-align:right'>Council of Arab
    Health Ministers<o:p></o:p></p>
    <p class=MsoNormal align=right style='text-align:right'>Union of Arab
    Pharmacists<o:p></o:p></p>
    <p class=MsoNormal><o:p>&nbsp;</o:p></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="margin"/>
</v:roundrect><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td colspan="2" style="vertical-align:top"><img width="649" height="320" alt="Rectangle: Rounded Corners: To report any side effect(s):

Kingdom of Saudi Arabia
-National Pharmacovigilance centre (NPC)
•	Reporting hotline: 19999
•	E-mail: npc.drug@sfda.gov.sa 
•	Website: https://ade.sfda.gov.sa
-GSK  - Head Office, Jeddah
•	Tel:  +966-12-6536666
•	Mobile: +966-56-904-9882
•	Email: saudi.safety@gsk.com   
•	website: https://gskpro.com/en-sa/ 
•	P.O. Box 55850, Jeddah 21544, Saudi Arabia
" src="file:///C:/Users/mh360004/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png" /></td></tr><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td colspan="2" style="vertical-align:top"><img width="649" height="235" alt="Rectangle: Rounded Corners: THIS IS A MEDICAMENT
- Medicament is a product which affects your health, and its consumption contrary to instructions is dangerous for you.
- Follow strictly the doctor’s prescription, the method of use and the instructions of the pharmacist who sold the medicament.
- The doctor and the pharmacist are experts in medicine, its benefits and risks.
- Do not by yourself interrupt the period of treatment prescribed for you.
- Do not repeat the same prescription without consulting your doctor.
- Keep all medicine out of reach of children
Council of Arab Health Ministers
Union of Arab Pharmacists

" src="file:///C:/Users/mh360004/AppData/Local/Temp/msohtmlclip1/01/clip_image002.png" /></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version number: UKSmPC 
Date of issue: 10/06/2021

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&nbsp;</p><p dir="RTL">تحتوي أقراص زوفيراكس 200 ملجم و400 ملجم و800 ملجم يطلق عليها في هذه النشرة &quot;زوفيراكس&quot; على دواء يسمى أسيكلوفير. وينتمي هذا الدواء إلى مجموعة من الأدوية يطلق عليها مضادات الفيروسات. &rlm;‫وهو يعمل عن طريق قتل الفيروسات أو وقف نموها.</p><p dir="RTL">يمكن استخدام زوفيراكس في:</p><p dir="RTL">&middot;&nbsp;&nbsp; علاج جديري الماء والهربس النطاقي</p><p dir="RTL">&middot;&nbsp;&nbsp; علاج قرحات الزكام والهربس التناسلي وغيره من حالات عدوى الهربس البسيط</p><p dir="RTL">&middot;&nbsp;&nbsp; منع تكرار حدوث هذه المشكلات بعد الإصابة بها</p><p dir="RTL">&middot;&nbsp;&nbsp; منع الإصابة بهذه الحالات المرضية بالنسبة للمرضى الذين يعانون من ضعف في أجهزتهم المناعية، مما يعني أن أجسامهم تكون أقل قدرة على مقاومة حالات العدوى</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم زوفيراكس:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp; في حالة وجود حساسية لمادة الأسيكلوفير أو الفالسيكلوفير أو لأيّ مكوّن من المكوّنات الأخرى الخاصة بهذا الدواء (المذكورة في القسم 6).</p><p dir="RTL">&rlm;‫لا تتناول زوفيراكس إذا كان ما سبق ينطبق عليك. وفي حالة عدم التأكد من ذلك، ينبغي استشارة الطبيب أو الصيدلاني قبل تناول زوفيراكس.</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">يجب استشارة الطبيب أو الصيدلاني قبل تناول زوفيراكس في الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في الكلى.</p><p dir="RTL">&middot;&nbsp;&nbsp; إذا كان عمرك يتجاوز 65 عامًا.</p><p dir="RTL">وعند عدم التأكد من مدى انطباق ما سبق عليك، يجب استشارة الطبيب أو الصيدلاني قبل تناول زوفيراكس.</p><p dir="RTL">من المهم أن تشرب قدرًا وفيرًا من الماء أثناء تناول زوفيراكس</p><p dir="RTL"><strong>زوفيراكس والأدوية الأخرى</strong></p><p dir="RTL">ينبغي إخبار الطبيب أو الصيدلاني إذا كنت تتناول أية أدوية أخرى أو تناولت أية أدوية أخرى مؤخرًا. &rlm;‫ويشمل ذلك الأدوية التي يتم الحصول عليها دون وصفة طبية، بما في ذلك الأدوية العشبية.</p><p dir="RTL">ينبغي إخبار الطبيب أو الصيدلاني بصفة خاصة في حالة تناول أي من الأدوية التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp; البروبينسيد، دواء يُستخدم لعلاج النقرس</p><p dir="RTL">&middot;&nbsp;&nbsp; السيميتيدين، دواء يُستخدم لعلاج قرح المعدة</p><p dir="RTL">&middot;&nbsp;&nbsp; ميكوفينوليت موفيتيل، دواء يُستخدم لمنع رفض الأعضاء المزروعة</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">في حالة الحمل أو الرضاعة الطبيعية أو إذا كنتِ تظنين أنكِ حامل أو تخططين للحمل، يجب استشارة الطبيب أو الصيدلاني قبل استخدام أي دواء.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد تضعف بعض الآثار الجانبية مثل الشعور بالنعاس أو النوم قدرتك على التركيز والاستجابة. تأكد من عدم تأثير الدواء عليك قبل القيادة أو تشغيل الآلات.</p><p dir="RTL">معلومات مهمة عن مكونات زوفريكس اقراص</p><p dir="RTL">يحتوي هذا الدواء على أقل من 1 ملي مول من الصوديوم (23 مجم) لكل جرعة 1 مل، وهذا يعني أنه &quot;خالي من الصوديوم&quot; بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول هذا الدواء دائمًا بالطريقة التي يوصي بها الطبيب بالضبط. وينبغي استشارة الطبيب أو الصيدلاني في حالة عدم التأكد من طريقة الاستعمال.</p><p dir="RTL"><strong>&rlm;</strong>‫<strong>طريقة تناول هذا الدواء</strong><strong>&rlm;</strong>‫<strong>&nbsp; </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول هذا الدواء عن طريق الفم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;&rlm;‫قم بإذابة القرص في كوب ماء وامزجه بالتحريك قبل شُربه</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تفضل ذلك، يمكن أيضًا ابتلاع القرص بكامله مع قليل من الماء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ابدأ في تناول زوفيراكس في أقرب وقت ممكن</p><p dir="RTL">&nbsp;</p><p dir="RTL">تعتمد الجرعة اللازم تناولها على دواعي استعمال زوفيراكس. وسيناقش معك الطبيب هذا الأمر.</p><p dir="RTL"><strong>علاج جديري الماء والهربس النطاقي</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة العادية هي أقراص 800 ملجم 5 مرات في اليوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وينبغي أن تكون الفترة بين كل جرعة والجرعة اللاحقة 4 ساعات</p><p dir="RTL">&rlm;الأوقات الموصى بتناول الجرعات فيها:<strong>الساعة 7 صباحًا، و11 صباحًا، و3 عصرًا، و7 مساءً،و11مساءً</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب تناول زوفيراكس لمدة سبعة أيام.</p><p dir="RTL"><strong>علاج القروح الباردة وحالات الهربس التناسلي</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة العادية هي قرص واحد 200 ملجم 5 مرات في اليوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وينبغي أن تكون الفترة بين كل جرعة والجرعة اللاحقة 4 ساعات</p><p dir="RTL">&rlm;‫الأوقات الموصى بتناول الجرعات فيها: <strong>الساعة 7 صباحًا، و11 صباحًا، و3 عصرًا، و7مساءً،و11مساءً</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب تناول زوفيراكس لمدة خمسة أيام أو لمدة أطول حسب توصيات الطبيب</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>منع تكرار الإصابة بهذه الحالات المرضية بعد الإصابة بها من قبل</strong><strong>&rlm;</strong>‫</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة العادية هي قرص واحد 200 ملجم 4 مرات في اليوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وينبغي أن تحاول أن تكون الفترة بين كل جرعة والجرعة اللاحقة 6 ساعات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب مواصلة تناول زوفيراكس حتى يطلب منك الطبيب التوقف عن تناوله.</p><p dir="RTL"><strong>منع الإصابة بهذه الحالات المرضية بالنسبة للمرضى الذين لديهم أجهزة مناعة ضعيفة، مما يعني أن أجسامهم تكون أقل قدرة على مقاومة حالات العدوى.</strong><strong>&rlm;</strong>‫</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة العادية هي قرص واحد 200 ملجم 4 مرات في اليوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وينبغي أن تحاول أن تكون الفترة بين كل جرعة والجرعة اللاحقة 6 ساعات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب مواصلة تناول زوفيراكس حتى يطلب منك الطبيب التوقف عن تناوله.</p><p dir="RTL"><strong>قد يقوم الطبيب بتعديل جرعة زوفيراكس في الحالات التالية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت الجرعة موصوفة لطفل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫إذا كان عمرك يتجاوز 65 عامًا</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫إذا كنت تعاني من مشاكل في الكلى. إذا كنت تعاني من مشاكل في الكلى، فمن المهم تناول كميات وفيرة من الماء أثناء العلاج بزوفيراكس</p><p dir="RTL">&rlm;‫يجب استشارة الطبيب قبل تناول زوفيراكس في حالة انطباق أي من الحالات السابقة عليك.&rlm;‫</p><p dir="RTL"><strong>&rlm;</strong>‫<strong>في حالة تجاوز الجرعة اللازمة من زوفيراكس</strong></p><p dir="RTL">لا يكون زوفيراكس ضارًا عادةً، إلا إذا تناولت كمية كبيرة للغاية منه على مدى عدة أيام. &rlm;‫يجب استشارة الطبيب أو الصيدلاني إذا تناولت جرعة كبيرة للغاية من زوفيراكس. &rlm;‫خذ عبوة الدواء معك.</p><p dir="RTL"><strong>في حالة نسيان تناول جرعة زوفيراكس</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; في حالة نسيان تناول زوفيراكس، يجب تناوله فور التذكّر. &rlm;‫ولكن في حالة اقتراب موعد الجرعة التالية، يمكنك تجاوز الجرعة الفائتة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ولا يجوز استخدام جرعة مضاعفة لتعويض الجرعة الفائتة&rlm;‫</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يتسبب هذا الدواء في حدوث آثار جانبية، على الرغم من أن هذه الآثار لا تحدث لجميع الأشخاص.&rlm;‫ &rlm;‫قد تحدث الآثار الجانبية التالية عند استخدام هذا الدواء:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&rlm;‫<strong>تفاعلات الحساسية</strong> (قد تصيب حتى شخص واحد من بين كل 1000 شخص)</p><p dir="RTL">إذا كنت تعاني من تفاعل تحسسي، <strong>فتوقف عن استخدام زوفيراكس</strong> <strong>واستشر طبيبًا على الفور</strong>. قد تشمل العلامات:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح أو حكة أو شرى على الجلد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في الوجه أو الشفتين أو اللسان أو أي جزء آخر من الجسم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق تنفس أو أزيز أو صعوبة في التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إغماء</p><p dir="RTL">&nbsp;</p><p dir="RTL">تشمل الآثار الجانبية الأخرى:</p><p dir="RTL"><strong>آثار جانبية شائعة</strong> (قد تصيب حتى شخص واحد من بين كل 10 أشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بدوار</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الغثيان أو التقيؤ</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام في المعدة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات جلدية بعد التعرض للضوء (حساسية ضوئية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالتعب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى (ارتفاع في درجة حرارة الجسم) بشكل لا يمكن تفسيره وشعور بدوخة، خاصة عند الوقوف</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية غير شائعة</strong> (قد تصيب حتى شخص واحد من بين كل 100 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مثير للحكة يشبه الشرى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية نادرة</strong> (قد تصيب حتى شخص واحد من بين كل 1000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التأثير على اختبارات الدم والبول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫ارتفاع في إنزيمات الكبد</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>آثار جانبية نادرة جدًا</strong> (قد تصيب حتى شخص واحد من بين كل 10000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم الحمراء (فقر الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم البيضاء (قلة الكريات البيض)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الصفائح الدموية (الخلايا التي تساعد على تجلط الدم) (قلة الصفيحات)&rlm;‫</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بضعف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور باضطراب أو ارتباك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتعاش أو ارتجاف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هلوسة (رؤية أشياء أو سماع أشياء غير موجودة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات تشنج</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالنوم أو النعاس بشكل غير معتاد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم الثبات عند المشي وفقد الاتزان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في الكلام</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم القدرة على التفكير وتقدير الأمور بشكل واضح</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫فقدان الوعي (الغيبوبة)&rlm;‫</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شلل في جزء من الجسم أو في كل أجزاء الجسم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في السلوك والكلام وحركات العين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تيبس الرقبة وحساسية تجاه الضوء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد (الوبائي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد وبياض العينين (اليرقان)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الكلى تتسبب في إخراج كمية ضئيلة من البول أو انعدام التبول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم أسفل الظهر، أو في منطقة الكلى في الظهر أو أعلى الورك مباشرةً (ألم كلوي)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><!--[if !supportLists]--><strong>&middot;</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>يحفظ بعيداً عن متناول ونظر الأطفال</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>زوﭬـيراكس</strong> لا يجوز إستعماله بعد تاريخ إنتهاء الصلاحية المبين على العبوة بعد كلمة &quot;Exp&quot;.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>زوﭬـيراكس</strong> يجب حفظه في العبوة الأصلية في مكان جاف بدرجة حرارة أقل من 25<sup>&deg;</sup>م. يجب صرف الأقراص في عبوات مقاومة للرطوبة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>زوﭬـيراكس </strong>لا يجوز إستعماله في حالة كسر الأقراص أو في حالة وجود علامات مرئية أخرى للتلف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أخبرك الطبيب بوقف تناول أقراص <strong>زوﭬـيراكس</strong>، فمن المهم إعادة أي كمية متبقية إلى الصيدلي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يجوز التخلص من الأدوية في مياه الصرف الصحي أو المخلفات المنـزلية. إسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه التدابير تساعد على وقاية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>محتويات أقراص زوفيراكس</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الفعالة:</p><p dir="RTL">تحتوي أقراص <strong>زوفيراكس</strong> 200 ملجم على 200 ملجم من الأسيكلوفير.</p><p dir="RTL">تحتوي أقراص <strong>زوفيراكس</strong> 400 ملجم على 400 ملجم من الأسيكلوفير.</p><p dir="RTL">تحتوي أقراص <strong>زوفيراكس</strong> 800 ملجم على 800 ملجم من الأسيكلوفير.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشمل المكوّنات الأخرى:</p><p dir="RTL">سليلوز دقيق التبلور، غليكولات النشاء الصودي، بوفيدون K30، سترات الماغنيسيوم، أحادي هيدرات اللاكتوز.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مظهر زوفيراكس ومحتويات العبوة</strong></p><p dir="RTL">PVC /PVdC/ فقاعات مغلفة برقائق الألومنيوم</p><p dir="RTL"><u>حجم العبوة:</u></p><p dir="RTL">زوفيراكس 200 ملجم: 25 قرصًا</p><p dir="RTL">زوفيراكس 400 ملجم: 70 قرصًا</p><p dir="RTL">زوفيراكس 800 ملجم: 35 قرصًا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>للإبلاغ عن أية آثار جانبية:</strong></p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- </strong><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong><strong>(NPC )</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاتصال بالرقم الموحد :19999</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>- جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666 (12) 966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال : 9882-904-56 &nbsp;966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد اللكتروني : <u>s</u>audi.safety@gsk.com&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: &nbsp;https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب 55850، جدة 21544، المملكة العربية السعودية.</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>للإبلاغ عن أية آثار جانبية:</strong></p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- </strong><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong><strong>(NPC )</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاتصال بالرقم الموحد :19999</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>- جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666 (12) 966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال : 9882-904-56 &nbsp;966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد اللكتروني : <u>s</u>audi.safety@gsk.com&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: &nbsp;https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب 55850، جدة 21544، المملكة العربية السعودية.</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>للإبلاغ عن أية آثار جانبية:</strong></p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- </strong><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong><strong>(NPC )</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاتصال بالرقم الموحد :19999</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>- جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666 (12) 966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال : 9882-904-56 &nbsp;966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد اللكتروني : <u>s</u>audi.safety@gsk.com&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: &nbsp;https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب 55850، جدة 21544، المملكة العربية السعودية.</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>للإبلاغ عن أية آثار جانبية:</strong></p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- </strong><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong><strong>(NPC )</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاتصال بالرقم الموحد :19999</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>- جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666 (12) 966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال : 9882-904-56 &nbsp;966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد اللكتروني : <u>s</u>audi.safety@gsk.com&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: &nbsp;https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب 55850، جدة 21544، المملكة العربية السعودية.</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>للإبلاغ عن أية آثار جانبية:</strong></p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- </strong><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong><strong>(NPC )</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاتصال بالرقم الموحد :19999</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>- جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666 (12) 966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال : 9882-904-56 &nbsp;966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد اللكتروني : <u>s</u>audi.safety@gsk.com&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: &nbsp;https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب 55850، جدة 21544، المملكة العربية السعودية.</p></td></tr></tbody></table><p dir="RTL"><strong>إن هذا الدواء</strong></p><p dir="RTL">- الدواء مستحضر يؤثر على صحتك، واستهلاكه خلافا للتعليمات يعرضك للخطر.</p><p dir="RTL">- اتبع بدقة وصفة الطبيب، وطريقة الاستعمال المنصوص عليها، وتعليمات الصيدلانى الذى صرفها لك.</p><p dir="RTL">- فالطبيب والصيدلانى هما الخبيران بالدواء، وبنفعه وضرره.</p><p dir="RTL">- لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.</p><p dir="RTL">- لا تكرر صرف الدواء بدون استشارة الطبيب.</p><p dir="RTL">- احتفظ بجميع الأدوية بعيداً عن متناول لأطفال.&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مجلس وزراء الصحة العرب</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; اتحاد الصيادلة العرب</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رقم الإصدار : المملكة المتحدة ،نشرة معلومات المريض .
تاريخ الإصدار: 10 يونيو 2021

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zovirax Tablets 200 mg, 400 mg and 800 mg.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aciclovir 200 mg, 400 mg and 800 mg.

Excipients with known effect: 
Each 200 mg tablet contains 0.44 mg of sodium. 
Each 400 mg tablet contains 0.88 mg of sodium. 
Each 800 mg tablet contains 1.76 mg of sodium. 

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dispersible film-coated tablet.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Zovirax Tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes (excluding neonatal HSV and severe HSV infections in immunocompromised children).</p><p>&nbsp;</p><p>Zovirax Tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immunocompetent patients.</p><p>&nbsp;</p><p>Zovirax Tablets are indicated for the prophylaxis of herpes simplex infections in immunocompromised patients.</p><p>&nbsp;</p><p>Zovirax Tablets are indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections, for Zovirax tablets 800 mg (excluding neonatal HSV and severe HSV infections in immunocompromised children).</p><p>&nbsp;</p><p>Zovirax 800mg tablets is recommended in children over the age of 6.</p><p>&nbsp;</p><p>Route of administration: Oral</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Zovirax tablets may be dispersed in a minimum of 50 ml of water or swallowed whole with a little water.&nbsp; Ensure that patients on high doses of aciclovir are adequately hydrated.</p><p>&nbsp;</p><p><u>Dosage in adults</u></p><p><u>&nbsp;</u></p><p><u>Treatment of herpes simplex infections:</u>&nbsp; 200 mg Zovirax should be taken five times daily at approximately four hourly intervals omitting the night time dose.&nbsp; Treatment should continue for 5 days, but in severe initial infections this may have to be extended.</p><p>&nbsp;</p><p>In severely immunocompromised patients (e.g. after marrow transplant) or in patients with impaired absorption from the gut the dose can be doubled to 400 mg Zovirax or alternatively intravenous dosing could be considered.</p><p>&nbsp;</p><p>Dosing should begin as early as possible after the start of an infection; for recurrent episodes this should preferably be during the prodromal period or when lesions first appear.</p><p>&nbsp;</p><p><u>Suppression of herpes simplex infections in immunocompetent patients:</u>&nbsp; 200 mg Zovirax should be taken four times daily at approximately six-hourly intervals.</p><p>&nbsp;</p><p>Many patients may be conveniently managed on a regimen of 400 mg Zovirax twice daily at approximately twelve-hourly intervals.</p><p>&nbsp;</p><p>Dosage titration down to 200 mg Zovirax taken thrice daily at approximately eight-hourly intervals or even twice daily at approximately twelve-hourly intervals may prove effective.</p><p>&nbsp;</p><p>Some patients may experience break-through infection on total daily doses of 800 mg Zovirax.</p><p>&nbsp;</p><p>Therapy should be interrupted periodically at intervals of six to twelve months, in order to observe possible changes in the natural history of the disease.</p><p>&nbsp;</p><p><u>Prophylaxis of herpes simplex infections in immunocompromised patients:</u>&nbsp; 200 mg Zovirax should be taken four times daily at approximately six-hourly intervals.</p><p>&nbsp;</p><p>In severely immunocompromised patients (e.g. after marrow transplant) or in patients with impaired absorption from the gut, the dose can be doubled to 400 mg Zovirax, or alternatively, intravenous dosing could be considered.</p><p>&nbsp;</p><p>The duration of prophylactic administration is determined by the duration of the period at risk.</p><p>&nbsp;</p><p><u>Treatment of varicella and herpes zoster infections</u>:&nbsp; 800 mg Zovirax should be taken five times daily at approximately four-hourly intervals, omitting the night time dose.&nbsp; Treatment should continue for seven days.</p><p>&nbsp;</p><p>In severely immunocompromised patients (e.g., after marrow transplant) or in patients with impaired absorption from the gut, consideration should be given to intravenous dosing.</p><p>&nbsp;</p><p>Dosing should begin as early as possible after the start of an infection: Treatment of herpes zoster yields better results if initiated as soon as possible after the onset of the rash.&nbsp; Treatment of chickenpox in immunocompetent patients should begin within 24 hours after onset of the rash.</p><p>&nbsp;</p><p><u>Dosage in children</u></p><p><u>&nbsp;</u></p><p><u>Treatment of herpes simplex infections, and prophylaxis of herpes simplex infections in the immunocompromised:</u> Children aged two years and over should be given adult dosages and children below the age of two years should be given <u>half</u> the adult dose.</p><p>&nbsp;</p><p>For treatment on neonatal herpes virus infections, intravenous aciclovir is recommended.</p><p>&nbsp;</p><p><u>Treatment of varicella infection</u></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>6 years and over:</p></td><td style="vertical-align:top"><p>800 mg Zovirax four times daily.</p></td></tr><tr><td style="vertical-align:top"><p>2 - 5 years:</p></td><td style="vertical-align:top"><p>400mg Zovirax four times daily.</p></td></tr><tr><td style="vertical-align:top"><p>Under 2 years:</p></td><td style="vertical-align:top"><p>200mg Zovirax four times daily.</p></td></tr></tbody></table><p>Treatment should continue for five days.</p><p>&nbsp;</p><p>Dosing may be more accurately calculated as 20 mg/kg bodyweight (not to exceed 800 mg) Zovirax four times daily.</p><p>&nbsp;</p><p>No specific data are available on the suppression of herpes simplex infections or the treatment of herpes zoster infections in immunocompetent children.</p><p>&nbsp;</p><p><u>Dosage in the elderly:</u>&nbsp;</p><p>&nbsp;</p><p>The possibility of renal impairment in the elderly must be considered and the dosage should be adjusted accordingly (see Dosage in renal impairment below).</p><p>&nbsp;</p><p>Adequate hydration of elderly patients taking high oral doses of aciclovir should be maintained.&nbsp;</p><p>&nbsp;</p><p><u>Dosage in renal impairment</u>:&nbsp;</p><p>&nbsp;</p><p>Caution is advised when administering aciclovir to patients with impaired renal function.&nbsp; Adequate hydration should be maintained.</p><p>&nbsp;</p><p>In the management of herpes simplex infections in patients with impaired renal function, the recommended oral doses will not lead to accumulation of aciclovir above levels that have been established safe by intravenous infusion.&nbsp; However, for patients with severe renal impairment (creatinine clearance less than 10 ml/minute) an adjustment of dosage to 200 mg aciclovir twice daily at approximately twelve-hourly intervals is recommended.</p><p>&nbsp;</p><p>In the treatment of herpes zoster infections, it is recommended to adjust the dosage to 800 mg aciclovir twice daily at approximately twelve - hourly intervals for patients with severe renal impairment (creatinine clearance less than 10 ml/minute), and to 800 mg aciclovir three times daily at intervals of approximately eight hours for patients with moderate renal impairment (creatinine clearance in the range 10 &ndash; 25 ml/minute).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to aciclovir or valaciclovir, or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Use in patients with renal impairment and in elderly patients:</em></strong></p><p>Aciclovir is eliminated by renal clearance, therefore the dose must be adjusted</p><p>in patients with renal impairment (see 4.2 Posology and Method of Administration).&nbsp; Elderly patients are likely to have reduced renal function and therefore the need for dose adjustment must be considered in this group of patients.&nbsp; Both elderly patients and patients with renal impairment are at increased risk of developing neurological side effects and should be closely monitored for evidence of these effects.&nbsp; In the reported cases, these reactions were generally reversible on discontinuation of treatment (see 4.8 Undesirable Effects).&nbsp; Prolonged or repeated courses of aciclovir in severely immune-compromised individuals may result in the selection of virus strains with reduced sensitivity, which may not respond to continued aciclovir treatment (see section 5.1).</p><p><em>&nbsp;</em></p><p><em>Hydration status</em>: Care should be taken to maintain adequate hydration in patients receiving high oral doses of aciclovir.</p><p>The risk of renal impairment is increased by use with other nephrotoxic drugs.</p><p>&nbsp;</p><p>The data currently available from clinical studies is not sufficient to conclude that treatment with aciclovir reduces the incidence of chickenpox-associated complications in immunocompetent patients.</p><p>&nbsp;</p><p>This medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that</p><p>is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aciclovir is eliminated primarily unchanged in the urine via active renal tubular secretion.&nbsp; Any drugs administered concurrently that compete with this mechanism may increase aciclovir plasma concentrations.&nbsp; Probenecid and cimetidine increase the AUC of aciclovir by this mechanism and reduce aciclovir renal clearance.&nbsp; Similarly increases in plasma AUCs of aciclovir and of the inactive metabolite of mycophenolate mofetil, an immunosuppresant agent used in transplant patients have been shown when the drugs are coadministered.&nbsp; However, no dosage adjustment is necessary because of the wide therapeutic index of aciclovir.</p><p>&nbsp;</p><p>An experimental study on five male subjects indicates that concomitant therapy with aciclovir increases AUC of totally administered <strong>theophylline</strong> with approximately 50%. It is recommended to measure plasma concentrations during concomitant therapy with aciclovir.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy:</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The use of aciclovir should be considered only when the potential benefits outweigh the possibility of unknown risks.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A post-marketing aciclovir pregnancy registry has documented pregnancy outcomes in women exposed to any formulation of Zovirax. The registry findings have not shown an increase in the number of birth defects amongst Zovirax exposed subjects compared with the general population, and any birth defects showed no uniqueness or consistent pattern to suggest a common cause. Systemic administration of aciclovir in internationally accepted standard tests did not produce embryotoxic or teratogenic effects in rabbits, rats or mice. In a non-standard test in rats, foetal abnormalities were observed but only following such high subcutaneous doses that maternal toxicity was produced. The clinical relevance of these findings is uncertain.</p><p>&nbsp;</p><p>Caution should however be exercised by balancing the potential benefits of treatment against any possible hazard. Findings from reproduction toxicology studies are included in Section 5.3.</p><p>&nbsp;</p><p><u>Breast-feeding</u>:</p><p>Following oral administration of 200 mg Zovirax five times a day, aciclovir has been detected in breast milk at concentrations ranging from 0.6 to 4.1 times the corresponding plasma levels.&nbsp; These levels would potentially expose nursing infants to aciclovir dosages of up to 0.3 mg/kg/day.&nbsp; Caution is therefore advised if aciclovir is to be administered to a nursing woman.</p><p><u>&nbsp;</u></p><p><u>Fertility:</u></p><p>There is no information on the effect of aciclovir on human female fertility.</p><p>In a study of 20 male patients with normal sperm count, oral aciclovir administered at doses of up to 1g per day for up to six months has been shown to have no clinically significant effect on sperm count, motility, or morphology.</p><p>See clinical studies in section 5.2.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There have been no studies to investigate the effect of aciclovir on driving performance or the ability to operate machinery. A detrimental effect on such activities cannot be predicted from the pharmacology of the active substance, but the adverse event profile should be borne in mind.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The frequency categories associated with the adverse events below are estimates.&nbsp; For most events, suitable data for estimating incidence were not available.&nbsp; In addition, adverse events may vary in their incidence depending on the indication.</p><p>The following convention has been used for the classification of undesirable effects in terms of frequency:- Very common &ge;1/10, common &ge;1/100 and &lt;1/10, uncommon &ge;1/1000 and &lt;1/100, rare &ge;1/10,000 and &lt;1/1000, very rare &lt;1/10,000.</p><p>&nbsp;</p><p><strong>Blood and lymphatic system disorders:</strong><br /><em>Very rare: </em>Anaemia, leukopenia, thrombocytopenia.</p><p>&nbsp;</p><p><strong>Immune system disorders:</strong></p><p><em>Rare: </em>Anaphylaxis.</p><p>&nbsp;</p><p><strong>Psychiatric and nervous system disorders:</strong></p><p><em>Common: </em>Headache, dizziness.</p><p><em>Very rare: </em>Agitation, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, convulsions, somnolence, encephalopathy, coma.&nbsp;</p><p>The above events are generally reversible and usually reported in patients with renal impairment or with other predisposing factors (see 4.4 Special Warnings and Precautions for Use).</p><p><u>&nbsp;</u></p><p><strong>Respiratory, thoracic and mediastinal disorders:</strong></p><p><em>Rare: </em>Dyspnoea.</p><p><u>&nbsp;</u></p><p><strong>Gastrointestinal disorders:</strong></p><p><em>Common: </em>Nausea, vomiting, diarrhoea, abdominal pains.</p><p>&nbsp;</p><p><strong>Hepato-biliary disorders:</strong></p><p><em>Rare:</em> Reversible rises in bilirubin and liver related enzymes.</p><p><em>Very rare:</em> Hepatitis, jaundice.</p><p><u>&nbsp;</u></p><p><strong>Skin and subcutaneous tissue disorders:</strong></p><p><em>Common: </em>Pruritus, rashes (including photosensitivity).</p><p><em>Uncommon: </em>Urticaria.&nbsp; Accelerated diffuse hair loss.&nbsp; Accelerated diffuse hair loss has been associated with a wide variety of disease processes and medicines, the relationship of the event to aciclovir therapy is uncertain.</p><p><em>Rare:</em> Angioedema.</p><p><u>&nbsp;</u></p><p><strong>Renal and urinary disorders:</strong></p><p><em>Rare: </em>Increases in blood urea and creatinine.</p><p><em>Very rare: </em>Acute renal failure, renal pain.</p><p>Renal pain may be associated with renal failure and crystalluria.</p><p><u>&nbsp;</u></p><p><strong>General disorders and administration site conditions:</strong></p><p><em>Common</em>: Fatigue, fever.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong><em>&nbsp;</em></strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting hotline: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: &nbsp;npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p><strong>-GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: <u>s</u>audi.safety@gsk.com<u>&nbsp; </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; website: https://gskpro.com/en-sa/<u> </u>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Symptoms and signs:-&nbsp; </em>Aciclovir is only partly absorbed in the gastrointestinal tract.&nbsp; Patients have ingested overdoses of up to 20g aciclovir on a single occasion, usually without toxic effects.&nbsp; Accidental, repeated overdoses of oral aciclovir over several days have been associated with gastrointestinal effects (such as nausea and vomiting) and neurological effects (headache and confusion).</p><p>&nbsp;</p><p>Overdosage of intravenous aciclovir has resulted in elevations of serum creatinine, blood urea nitrogen and subsequent renal failure.&nbsp; Neurological effects including confusion, hallucinations, agitation, seizures and coma have been described in association with intravenous overdosage.</p><p>&nbsp;</p><p>Management:-&nbsp; Patients should be observed closely for signs of toxicity.&nbsp; Haemodialysis significantly enhances the removal of aciclovir from the blood and may, therefore, be considered a management option in the event of symptomatic overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Direct acting antivirals, Nucleosides and nucleotides excl. reverse transcriptase inhibitors</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ATC code: J05AB01.</p><p>&nbsp;</p><p>&nbsp;</p><p>Aciclovir is a synthetic purine nucleoside analogue with <em>in vitro</em> and <em>in vivo</em> inhibitory activity against human herpes viruses, including herpes simplex virus (HSV) types I and II and varicella zoster virus (VZV).</p><p>&nbsp;</p><p>The inhibitory activity of aciclovir for HSV I, HSV II and VZV is highly selective. The enzyme thymidine kinase (TK) of normal, uninfected cells does not use aciclovir effectively as a substrate, hence toxicity of mammalian host cells is low; however, TK encoded by HSV and VZV converts aciclovir to aciclovir monophosphate, a nucleoside analogue which is further converted to the diphosphate and finally to the triphosphate by cellular enzymes. Aciclovir triphosphate interferes with the viral DNA polymerase and inhibits viral DNA replication with resultant chain termination following its incorporation into the viral DNA.</p><p>&nbsp;</p><p>Prolonged or repeated courses of aciclovir in severely immune-compromised individuals may result in the selection of virus strains with reduced sensitivity, which may not respond to continued aciclovir treatment.&nbsp; Most of the clinical isolates with reduced sensitivity have been relatively deficient in viral TK, however, strains with altered viral TK or viral DNA polymerase have also been reported. <em>In vitro</em> exposure of HSV isolates to aciclovir can also lead to the emergence of less sensitive strains. The relationship between the <em>in vitro</em> determined sensitivity of HSV isolates and clinical response to aciclovir therapy is not clear.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Aciclovir is only partially absorbed from the gut. The average oral bioavailability varies between 10 and 20%. Under fasting conditions, mean peak concentrations (C<sub>max</sub>) of 0.4 microgram/ml are achieved at approximately 1.6 hours after a 200 mg dose administered as oral suspension or capsule. Mean peak plasma concentrations (C<sub>ssmax</sub>) increase to 0.7&nbsp;microgram/ml (3.1 micromoles) at steady state following doses of 200&nbsp;mg administered every four hours. A less than proportional increase is observed for C<sub>ssmax </sub>concentration following doses of 400&nbsp;mg and 800&nbsp;mg administered four-hourly, with values reaching 1.2&nbsp; and 1.8 microgram/ml (5.3 and 8 micromoles), respectively.</p><p>&nbsp;</p><p><u>Distribution</u></p><p>&nbsp;</p><p>The mean volume of distribution of 26 L indicates that aciclovir is distributed within total body water. Apparent values after oral administration (Vd/F) ranged from 2.3 to 17.8 L/kg. As plasma protein binding is relatively low (9 to 33%), drug interactions involving binding site displacement are not anticipated. Cerebrospinal fluid concentration are approximately 50% of corresponding plasma concentration at steady-state.</p><p>&nbsp;</p><p><u>Metabolism</u></p><p>&nbsp;</p><p>Aciclovir is predominantly excreted unchanged by the kidney. The only significant urinary metabolite is 9-[(carboxymethoxy) methyl]guanine, and accounts for 10-15% of the dose excreted in the urine.</p><p>&nbsp;</p><p><u>Elimination</u></p><p>&nbsp;</p><p>In adults mean systemic exposure (AUC0-&infin;) to aciclovir ranges between 1.9 and 2.2 microgram*h/mL after a 200 mg dose. At this dose, the mean terminal plasma half-life after oral administration has been shown to vary between 2.8 and 4.1 hours.</p><p>Renal clearance of aciclovir (CLr= 14.3 L/h) is substantially greater than creatinine clearance, indicating that tubular secretion, in addition to glomerular filtration, contributes to the renal elimination of the drug. The half-life and total clearance of aciclovir are dependent on renal function. Therefore, dosage adjustment is recommended for renally impaired patients.</p><p>&nbsp;</p><p>There are no pharmacokinetic data for the oral formulation in neonates. The only available pharmacokinetic data are for the IV formulation in this age group.</p><p>&nbsp;</p><p><strong><em>Special patient populations</em></strong></p><p>&nbsp;</p><p><u>Elderly</u></p><p>In the elderly patients with normal renal function total clearance falls with increasing age due to decreases in creatinine clearance. However, the possibility of renal impairment in the elderly must be considered and the dosage should be adjusted accordingly.</p><p>&nbsp;</p><p><u>Renal impairment</u></p><p>In patients with chronic renal failure the mean terminal half-life was found to be 19.5 hours.&nbsp; The mean aciclovir half-life during haemodialysis was 5.7 hours.&nbsp; Plasma aciclovir concentration dropped approximately 60% during dialysis.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Mutagenicity</em>: - The results of a wide range of mutagenicity tests <em>in vitro</em> and <em>in vivo</em> indicate that aciclovir is unlikely to pose a genetic risk to man.&nbsp;</p><p><em>Carcinogenicity</em>: - Aciclovir was not found to be carcinogenic in long term studies in the rat and the mouse.&nbsp;</p><p><em>Teratogenicity</em>: - Systemic administration of aciclovir in internationally accepted standard tests did not produce embryotoxic or teratogenic effects in rats, rabbits or mice.</p><p>In a non-standard test in rats, foetal abnormalities were observed, but only following such high subcutaneous doses that maternal toxicity was produced.&nbsp; The clinical relevance of these findings is uncertain.</p><p><em>Fertility</em>: - Largely reversible adverse effects on spermatogenesis in association with overall toxicity in rats and dogs have been reported only at doses of aciclovir greatly in excess of those employed therapeutically.&nbsp; Two generation studies in mice did not reveal any effect of aciclovir on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top; width:221.3pt"><p>Zovirax Tablets 200</p></td><td style="vertical-align:top; width:221.35pt"><p>Zovirax Tablets 400 &amp; 800</p></td></tr><tr><td style="vertical-align:top; width:221.3pt"><p>Purified Water</p><p>Lactose monohydrate</p><p>Microcrystalline Cellulose</p><p>Sodium Starch Glycollate</p><p>Povidone K30</p><p>Magnesium Stearate</p></td><td style="vertical-align:top; width:221.35pt"><p>Purified Water</p><p>Microcrystalline Cellulose</p><p>Sodium Starch Glycollate</p><p>Povidone K30</p><p>Magnesium Stearate</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg;C, Keep dry.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PVC/PVdC/ Aluminium foil blister packs.</p><p><u>Pack size:</u></p><p>Zovirax 200 mg : 25 Tablets</p><p>Zovirax 400 mg : 70 Tablets</p><p>Zovirax 800 mg : 35 Tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p><p><strong>Administrative Data</strong></p><p>Version number: UK SPC issue 15 draft1</p><p>Date of issue: 10/06/2021</p><p><em>ZOVIRAX</em> is a trademark owned by or licensed to GSK group of companies.</p><p>&nbsp;</p><p>&copy; 2024 GSK group of companies.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorisation Holder
Glaxo Saudi Arabia Limited, Jeddah*, Saudi Arabia
*Member of the GlaxoSmithKline group of companies

Manufacture site
Glaxo Wellcome S.A.*, Aranda, Spain
Avenida de Extremadura, 3. 09400 Aranda de Duero, Burgos (Spain)
Packaged by
Glaxo Saudi Arabia Ltd.* Jeddah, Kingdom of Saudi Arabia


Manufacture site
Glaxo Wellcome S.A.*, Aranda, Spain
Avenida de Extremadura, 3. 09400 Aranda de Duero, Burgos (Spain)
Packaged by
Glaxo Saudi Arabia Ltd.* Jeddah, Kingdom of Saudi Arabia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Administrative Data
Version number: UK SPC issue 15 draft1
Date of issue: 10/06/2021

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>